|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0095 | (2013.01) | ||
| A61J 1/00 | (2023.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 9/10 | (2013.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61J 1/1412 | (2013.01) |
| (11) | Number of the document | 3799861 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20199781.4 |
| Date of filing the European patent application | 2020-10-02 | |
| (97) | Date of publication of the European application | 2021-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201962911035 P | 2019-10-04 | US | |
| 201962911689 P | 2019-10-07 | US | |
| 202063062785 P | 2020-08-07 | US |
| (72) |
Clancy, Maurice Joseph Anthony , IE
McDaid, Dennis Mark , IE
Flynn, Damien Patrick , IE
|
| (73) |
Xeolas Pharmaceuticals Ltd. ,
DCU Campus, Dublin 9,
IE
|
| (54) | PEDIATRIC SUSPENSION FORMULATION |
| PEDIATRIC SUSPENSION FORMULATION |